Issandou M, Bouillot A, Brusq JM, Forest MC, Grillot D, Guillard R, Martin S, Michiels C, Sulpice T, Daugan A.
Pharmacological inhibition of Stearoyl-CoA Desaturase 1 improves insulin sensitivity in insulin-resistant rat models.
Eur J Pharmacol. 2009 Jul 17. [Epub ahead of print]
Sulpice T, Prunet-Marcassus B, Molveaux C, Cani P, Vitte PA, Graber P, Dreano M, Burcelin R.
An adiponectin-like molecule with antidiabetic properties.
Endocrinology. 2009 Jul 16. [Epub ahead of print]
Briand F, Naik SU, Fuki I, Millar JS, Macphee C, Walker M, Billheimer J, Rothblat G, Rader DJ.
Both the Peroxisome Proliferator-Activated Receptor Agonist, GW0742, and Ezetimibe Promote Reverse Cholesterol Transport in Mice by Reducing Intestinal Reabsorption of HDL-Derived Cholesterol.
Clin trans Sci. 2009; 2:127-133.
Poglio S, Galvani S, Bour S, André M, Prunet-Marcassus B, Pénicaud L, Casteilla L, Cousin B.
Adipose tissue sensitivity to radiation exposure.
Am J Pathol. 2009 Jan;174(1):44-53.
Briand F, Bailhache E, Andre A, Magot T, Krempf M, Nguyen P, Ouguerram K.
The hyperenergetic-fed obese dog, a model of disturbance of apolipoprotein B-100 metabolism associated with insulin resistance: kinetic study using stable isotopes.
Metabolism. 2008 Jul;57(7):966-72.
Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R.
Metabolic endotoxemia initiates obesity and insulin resistance.
Diabetes. 2007 Jul;56(7):1761-72.
Fyfe MC, White JR, Taylor A, Chatfield R, Wargent E, Printz RL, Sulpice T, McCormack JG, Procter MJ, Reynet C, Widdowson PS, Wong-Kai-In P.
Glucokinase activator PSN-GK1 displays enhanced antihyperglycaemic and insulinotropic actions.
Diabetologia. 2007 Jun;50(6):1277-87.
Briand F, Bailhache E, Nguyen P, Krempf M, Magot T, Ouguerram K.
Metabolism of high density lipoprotein apolipoprotein A-I and cholesteryl ester in insulin resistant dog: a stable isotope study.
Diabetes Obes Metab. 2007 Jan;9(1):139-42.
Serisier S, Briand F, Ouguerram K, Siliart B, Magot T, Nguyen P.
Fenofibrate lowers lipid parameters in obese dogs.
J Nutr. 2006 Jul;136(7 Suppl):2037S-2040S.
Briand F, Serisier S, Krempf M, Siliart B, Magot T, Ouguerram K, Nguyen P.
Atorvastatin increases intestinal cholesterol absorption in dogs.
J Nutr. 2006 Jul;136(7 Suppl):2034S-2036S.
Briand F, Magot T, Krempf M, Nguyen P, Ouguerram K.
Effects of atorvastatin on high-density lipoprotein apolipoprotein A-I metabolism in dogs.
Eur J Clin Invest. 2006 Apr;36(4):224-30.
Prunet-Marcassus B, Cousin B, Caton D, André M, Pénicaud L, Casteilla L.
From heterogeneity to plasticity in adipose tissues: site-specific differences.
Exp Cell Res. 2006 Apr 1;312(6):727-36.
Berthonneche C, Sulpice T, Tanguy S, O'Connor S, Herbert JM, Janiak P, de Leiris J, Boucher F.
AT1 receptor blockade prevents cardiac dysfunction after myocardial infarction in rats.
Cardiovasc Drugs Ther. 2005 Aug;19(4):251-9.
Carmona MC, Louche K, Nibbelink M, Prunet B, Bross A, Desbazeille M, Dacquet C, Renard P, Casteilla L, Pénicaud L.
Fenofobrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
Int J Obes, 2005 Jul;29(7):864-71.
Ouguerram K, Nguyen P, Krempf M, Pouteau E, Briand F, Bailhache E, Magot T.
Selective uptake of high density lipoproteins cholesteryl ester in the dog, a species lacking in cholesteryl ester transfer protein activity; An in vivo approach using stable isotopes.
Comp Biochem Physiol B Biochem Mol Biol. 2004 Aug;138(4):339-45.
Bailhache E, Briand F, Nguyen P, Krempf M, Magot T, Ouguerram K.
Metabolism of cholesterol ester of apolipoprotein B100-containing lipoproteins in dogs: evidence for disregarding cholesterol ester transfer.
Eur J Clin Invest. 2004 Aug;34(8):527-34.
Berthonneche C, Sulpice T, Boucher F, Gouraud L, de Leiris J, O'Connor SE, Herbert JM, Janiak P. New insights into the pathological role of TNF-alpha in early cardiac dysfunction and subsequent heart failure after infarction in rats.
Am J Physiol Heart Circ Physiol. 2004 Jul;287(1):H340-50.
Prunet-Marcassus B, Desbazeille M, Bros A, Louche K, Delagrange P, Renard P, Casteilla L, Pénicaud L.
Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity.
Endocrinology. 2003 Dec;144(12):5347-52.
Leducq N, Bono F, Sulpice T, Vin V, Janiak P, Fur GL, O'Connor SE, Herbert JM.
Role of peripheral benzodiazepine receptors in mitochondrial, cellular, and cardiac damage induced by oxidative stress and ischemia-reperfusion.
J Pharmacol Exp Ther. 2003 Sep;306(3):828-37.
Prunet-Marcassus B, Ambid L, Viguerie-Bascands N, Pénicaud L, Casteilla L.
Evidence for a direct effect of melatonin on mitochondrial genome expression of Siberian hamster brown adipocytes.
J Pineal Res. 2001 Mar;30(2):108-15.
Prunet-Marcassus B, Moulin K, Carmona MC, Villarroya F, Pénicaud L, Casteilla L.
Inverse distribution of uncoupling proteins expression and oxidative capacity in mature adipocytes and stromal-vascular fractions of rat white and brown adipose tissues.
FEBS Lett. 1999 Dec 31;464(3):184-8.
Pucheu S, Boucher F, Sulpice T, Tresallet N, Bonhomme Y, Malfroy B, de Leiris J.
EUK-8 a synthetic catalytic scavenger of reactive oxygen species protects isolated iron-overloaded rat heart from functional and structural damage induced by ischemia/reperfusion.
Cardiovasc Drugs Ther. 1996 Jul;10(3):331-9.
Sulpice T, Boucher F, de Leiris J.
Limiting lipid peroxidation in the nonischemic zone of infarcted rat hearts by indomethacin improves left ventricular function without affecting myocardial healing and remodeling.
Am Heart J. 1996 Apr;131(4):681-8.
Sulpice T, Boucher F, Pucheu S, de Leiris J.
Contribution of leukocyte infiltration to lipoperoxidation occurring in the non-ischemic region of the rat heart submitted to permanent left coronary artery occlusion.
J Mol Cell Cardiol. 1994 Jul;26(7):831-40.